Citation:Montezuma D, Azevedo R, Lopes P, Vieira R, Cunha AL, Henrique R 2013

From Cancer Guidelines Wiki

Citation


Montezuma D, Azevedo R, Lopes P, Vieira R, Cunha AL, Henrique R. A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens. Virchows Arch 2013 Dec;463(6):749-54 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24126803.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Montezuma D, Azevedo R, Lopes P, Vieira R, Cunha AL, Henrique R 2013When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Montezuma_D,_Azevedo_R,_Lopes_P,_Vieira_R,_Cunha_AL,_Henrique_R_2013&oldid=106802"